Amylyx Pharmaceuticals, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2024-05-09: Form 10-Q; Item Smaller reporting company; As filed No.
- 2024-02-22: Form 10-K; Item Smaller reporting company; As filed No.
- 2023-11-09: Form 10-Q; Item Smaller reporting company; As filed No.
- 2023-11-09: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2024-05-09 | 10-Q | Smaller reporting company | No |
| 2024-02-22 | 10-K | Smaller reporting company | No |
| 2023-11-09 | 10-Q | Smaller reporting company | No |
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
| 2023-08-10 | 10-Q | Smaller reporting company | No |
| 2023-08-10 | 10-Q | Emerging growth company | Yes |
| 2023-05-11 | 10-Q | Smaller reporting company | No |
| 2023-05-11 | 10-Q | Emerging growth company | Yes |
| 2023-03-13 | 10-K | Emerging growth company | Yes |
| 2022-11-10 | 10-Q | Emerging growth company | Yes |
| 2022-08-11 | 10-Q | Emerging growth company | Yes |
| 2022-05-12 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |